| Time-varying covariates and coefficients in Cox regression models |
55 |
| Mitochondria and cardiovascular diseases-from pathophysiology to treatment |
44 |
| New insights into the mechanisms of pulmonary edema in acute lung injury |
34 |
| Congenital disorders of glycosylation |
31 |
| Lysosomal storage disease overview |
31 |
| Minimally invasive anterior, lateral, and oblique lumbar interbody fusion: a literature review |
28 |
| Solid organ transplantation in the 21st century |
28 |
| Financial toxicity and implications for cancer care in the era of molecular and immune therapies |
27 |
| Concise update on colorectal cancer epidemiology |
26 |
| Tau in neurodegenerative disease |
24 |
| Opening the black box of neural networks: methods for interpreting neural network models in clinical applications |
23 |
| Advanced small cell lung cancer (SCLC): new challenges and new expectations |
20 |
| In-depth mining of clinical data: the construction of clinical prediction model with R |
19 |
| Glycogen metabolism and glycogen storage disorders |
19 |
| Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy |
18 |
| Ground glass opacities management in the lung cancer screening era |
18 |
| Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer |
17 |
| Ultrasound-guided preoperative single-dose erector spinae plane block provides comparable analgesia to thoracic paravertebral block following thoracotomy: a single center randomized controlled double-blind study |
17 |
| Fatty acid oxidation disorders |
17 |
| Severe sepsis and cardiac arrhythmias |
17 |
| MicroRNAs as biomarkers of acute lung injury |
16 |
| Decision curve analysis: a technical note |
16 |
| Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma |
16 |
| Anticoagulant therapy in acute respiratory distress syndrome |
15 |
| Insights into the immuno-pathogenesis of acute respiratory distress syndrome |
15 |
| Insulin autoimmune syndrome: from diagnosis to clinical management |
14 |
| Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts |
14 |
| Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders |
14 |
| NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives |
13 |
| Atherosclerosis as autoimmune disease |
13 |
| Progress and challenges of gene therapy for Pompe disease |
13 |
| Innate immune activation in Alzheimer's disease |
13 |
| Amino acid disorders |
13 |
| Percutaneous endoscopic cervical discectomy: a technical review |
13 |
| Is mechanical power the final word on ventilator-induced lung injury?-no |
13 |
| Extracting and utilizing electronic health data from Epic for research |
12 |
| Neurologic impairment in Wilson disease |
12 |
| Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau? |
12 |
| Liquid biopsy for lung cancers: an update on recent developments |
12 |
| MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives |
12 |
| Predictive analytics with gradient boosting in clinical medicine |
12 |
| Multisystem late onset Pompe disease (LOPD): an update on clinical aspects |
12 |
| Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients |
11 |
| M2 macrophages promote pulmonary endothelial cells regeneration in sepsis-induced acute lung injury |
11 |
| Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers |
11 |
| The role of microRNA in the resistance to treatment of hepatocellular carcinoma |
11 |
| The 8th TNM edition for lung cancer: a critical analysis |
11 |
| Tumor progression: the neuronal input |
11 |
| Metabolomics: a challenge for detecting and monitoring inborn errors of metabolism |
11 |
| Non-operative treatment options for knee osteoarthritis |
11 |
